Manish Agrawal, M.D.

Chief Executive Officer, Co-Founder

Fellowship at the National Cancer Institute, National Institutes of Health. Residency at Georgetown University Medical Center. Master’s degree in philosophy from Georgetown University. Master’s degree in clinical research from Duke University. Bachelor’s degree in electrical and electronic engineering from Auburn University.

Attending physician and Co-Director of Clinical Research at Maryland Oncology Hematology.

Group psychedelic therapy: empirical estimates of cost-savings and improved access
Psilocybin‐assisted group therapy in patients with cancer diagnosed with a major depressive disorder
Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder
Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis
Developing a Direct Observation Measure of Therapeutic Connection in Psilocybin-Assisted Therapy: A Feasibility Study
Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder
Psilocybin-assisted therapy improves psycho-social-spiritual well-being in cancer patients
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?

Healing is a nuanced and lifelong process, but seeing a spark from a single session ignite this journey continues to surprise and humble me.

Role

He currently serves as Founder & CEO of Sunstone Therapies, a leader in the delivery of psychedelic-assisted therapy in the medical setting and the development and execution of clinical trials for those affected by complex mental health challenges.